Thesis April 2011 Lyx
Anti VEGF Therapy in Ophthalmology
SUTENT® (sunitinib malate) Slide Kit
The 15th International Symposium on Anti-Angiogenic Therapy: Recent Advances and Future Directions in Basic and Clinical Care Research
Breast Cancer
Second line chemotherapy for ovarian cancer
1 Royal Marsden Hospital, London, UK; 2 The Christie Hospital, Manchester, UK
Phase 1 Study of ACE-041, a First-in-Class Inhibitor of Vascular Development in Patients with Advanced Solid and Hematologic Tumors N. G. Borgstein 1,
Angiogenesis in Viral Immunoinflammatory Lesions
